Legato Capital Management’s Harvard Bioscience HBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,347	Closed	-$29.1K	–	798
2025 Q4	$29.1K	Buy	4,347 +2,946	+210%	+$17.5K	﹤0.01%	746
2025 Q3	$6.14K	Hold	1,401	–	–	﹤0.01%	558
2025 Q2	$6.21K	Sell	1,401 -69	-5%	-$288	﹤0.01%	562
2025 Q1	$8.32K	Hold	1,470	–	–	﹤0.01%	563
2024 Q4	$31K	Sell	1,470 -2,173	-60%	-$49.9K	﹤0.01%	561
2024 Q3	$98K	Hold	3,643	–	–	0.01%	538
2024 Q2	$104K	Buy	3,643 +140	+4%	+$4.91K	0.01%	538
2024 Q1	$149K	Buy	3,503 +301	+9%	+$13.5K	0.02%	538
2023 Q4	$171K	Hold	3,202	–	–	0.02%	535
2023 Q3	$138K	Sell	3,202 -1,779	-36%	-$82.1K	0.02%	522
2023 Q2	$273K	Sell	4,981 -1,799	-27%	-$98.7K	0.04%	489
2023 Q1	$285K	Hold	6,780	–	–	0.05%	418
2022 Q4	$188K	Buy	+6,780	New	+$167K	0.04%	456